Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer

Chromodomain-helicase-DNA-binding protein 4 (CHD4) is an epigenetic regulator identified as an oncogenic element that may provide a novel therapeutic target for the treatment of breast cancer (BC). CHD4—the core component of the nucleosome remodeling and deacetylase (NuRD) complex—may be mutated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Novillo, Apolonia, Fernández-Santander, Ana, Gaibar, Maria, Galán, Miguel, Romero-Lorca, Alicia, El Abdellaoui-Soussi, Fadoua, Gómez-del Arco, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107472/
https://www.ncbi.nlm.nih.gov/pubmed/33981601
http://dx.doi.org/10.3389/fonc.2021.633233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107472/
https://www.ncbi.nlm.nih.gov/pubmed/33981601
http://dx.doi.org/10.3389/fonc.2021.633233

Ejemplares similares